- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00482768
Improving Risk Factors for Diabetes Complications in Primary Care
15. mars 2018 oppdatert av: The University of Texas Health Science Center at San Antonio
The purpose of this study is to test an intervention in primary care clinics to improve three risk factors for diabetes complications: glucose control, blood pressure and cholesterol.
Subjects in the study will be clinic staff and clinicians, not patients.
The intervention is Practice Facilitation.
Practice facilitation occurs when a trained facilitator meets with a team of staff and clinicians in each practice over a period of several months.
Facilitation meetings create time for learning and reflection by members of the team and improves their communication so that they can adopt and implement a strategy to improve patient care
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Current control of hemoglobin A1c, blood pressure and lipids among patients with type 2 diabetes in primary care settings is not adequate to prevent complications.
Results from an NIDDK funded R34 pilot study conducted by members of this research team suggest that Practice Facilitation is feasible and may improve these risk factors.
Practice facilitation occurs when a trained facilitator meets with a team of staff and clinicians in each practice over a period of several months.
Facilitation meetings create time for learning and reflection by members of the team and improves their communication so that they can adopt and implement a strategy to improve patient care.
The purpose of this study is to use a Practice Facilitation intervention to improve the above three risk factors among patients with type 2 diabetes in small, autonomous primary care practices.
This intervention is based on complex adaptive system theory to support the selection, tailoring and implementation of one or more strategies to improve the above 3 risk factors in each intervention practice.
Five strategies will be discussed during the facilitation to stimulate change in each practice: a diabetes registry, point-of-care testing of HbA1c and lipids, group clinic visits, improved decision support during the visit, and patient activation prior to each visit.
The specific objectives are : 1) To evaluate the effectiveness and sustainability of practice facilitation to improve risk factors for type 2 diabetes complications across a variety of primary care settings; 2) Assess the implementation of the chronic care model(CCM) in response to the intervention; 3) Examine the relationship between communication within the practice team and the implementation of the CCM model; and 4) From the perspective of the organization conducting the intervention and the primary care practice, examine the cost of implementing the intervention relative to risk factor change.
The study will be a cluster randomized trial conducted in 40 primary care practices randomized to intervention or control.
Data will be collected on all practices and 40 patients in each practice using a multi-method assessment process at baseline, 12 and 24 months.
The intervention will be a series of 15 visits to 20 intervention practices by trained facilitators over 12 months.
Primary hypotheses will be tested with 12 month outcome data.
Sustainability of the intervention will be tested with 24 month data.
Insights will be included in a delayed intervention conducted in control practices and evaluated in a pre-post design.
Studietype
Intervensjonell
Registrering (Faktiske)
2493
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Texas
-
San Antonio, Texas, Forente stater, 78229-4404
- University of Texas Health Sciences Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Primary care practice with 5 or fewer physicians
- The practice must have seen at least 50 patients with type 2 diabetes in the past 90 days
Exclusion Criteria:
- Practice owned by a large vertically integrated health care system
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: 1
Intervention clinics will receive practice facilitation visits at regular intervals over a 12-month period.
|
Clinics in the experimental arm will meet with a trained facilitator to work on change strategies that will improve risk factors for diabetes complications.
|
Ingen inngripen: 2
Control clinics will deliver usual care for patients with diabetes.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
glycosylated hemoglobin
Tidsramme: 36 months
|
36 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
systolic blood pressure
Tidsramme: 36 months
|
36 months
|
LDL-cholesterol
Tidsramme: 36 months
|
36 months
|
Change in risk of coronary heart disease
Tidsramme: 36 months
|
36 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Polly H Noel, PhD, University of Texas Health Science Center-San Antonio
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Parchman ML, Pugh JA, Culler SD, Noel PH, Arar NH, Romero RL, Palmer RF. A group randomized trial of a complexity-based organizational intervention to improve risk factors for diabetes complications in primary care settings: study protocol. Implement Sci. 2008 Mar 5;3:15. doi: 10.1186/1748-5908-3-15.
- Noel PH, Lanham HJ, Palmer RF, Leykum LK, Parchman ML. The importance of relational coordination and reciprocal learning for chronic illness care within primary care teams. Health Care Manage Rev. 2013 Jan-Mar;38(1):20-8. doi: 10.1097/HMR.0b013e3182497262.
- Bowers KW, Robertson M, Parchman ML. How inclusive leadership can help your practice adapt to change. Fam Pract Manag. 2012 Jan-Feb;19(1):8-11. No abstract available.
- Culler SD, Parchman ML, Lozano-Romero R, Noel PH, Lanham HJ, Leykum LK, Zeber JE. Cost estimates for operating a primary care practice facilitation program. Ann Fam Med. 2013 May-Jun;11(3):207-11. doi: 10.1370/afm.1496.
- Mackey K, Parchman ML, Leykum LK, Lanham HJ, Noel PH, Zeber JE. Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier. Prim Care Diabetes. 2012 Jul;6(2):137-42. doi: 10.1016/j.pcd.2011.12.004. Epub 2012 Jan 20.
- Arar NH, Noel PH, Leykum L, Zeber JE, Romero R, Parchman ML. Implementing quality improvement in small, autonomous primary care practices: implications for the patient-centred medical home. Qual Prim Care. 2011;19(5):289-300.
- Parchman ML, Noel PH, Culler SD, Lanham HJ, Leykum LK, Romero RL, Palmer RF. A randomized trial of practice facilitation to improve the delivery of chronic illness care in primary care: initial and sustained effects. Implement Sci. 2013 Aug 22;8:93. doi: 10.1186/1748-5908-8-93.
- Noel PH, Parchman ML, Palmer RF, Romero RL, Leykum LK, Lanham HJ, Zeber JE, Bowers KW. Alignment of patient and primary care practice member perspectives of chronic illness care: a cross-sectional analysis. BMC Fam Pract. 2014 Mar 29;15:57. doi: 10.1186/1471-2296-15-57.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. juni 2007
Primær fullføring (Faktiske)
1. april 2012
Studiet fullført (Faktiske)
1. mai 2013
Datoer for studieregistrering
Først innsendt
4. juni 2007
Først innsendt som oppfylte QC-kriteriene
4. juni 2007
Først lagt ut (Anslag)
5. juni 2007
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
19. mars 2018
Siste oppdatering sendt inn som oppfylte QC-kriteriene
15. mars 2018
Sist bekreftet
1. mars 2011
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- R18DK075692 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Type 2 diabetes
-
Jin-Hee AhnAsan Medical CenterUkjentHER-2 genamplifikasjon | HER-2 Protein Overekspresjon
-
The University of Tennessee, KnoxvilleFullførtMattelærere (2.–8. klasse) | Mattestudenter (2.–8. klasse)Forente stater
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UkjentSolid svulst | HER-2 genamplifikasjon | HER2 genmutasjon | HER-2 Protein OverekspresjonKina
-
PowderMedFullført
-
AIM Vaccine Co., Ltd.Zhejiang Provincial Center for Disease Control and PreventionHar ikke rekruttert ennå
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...Har ikke rekruttert ennå
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical CollegeAktiv, ikke rekrutterende
-
AIM Vaccine Co., Ltd.Hunan Provincial Center for Disease Control and PreventionFullført
-
Indiana UniversityFullførtSARS-CoV-2Forente stater
-
Peking UniversityCenters for Disease Control and Prevention, China; Beijing Pinggu District... og andre samarbeidspartnereFullført
Kliniske studier på Practice Facilitation
-
Icahn School of Medicine at Mount SinaiBrain Injury Association of PennsylvaniaRekrutteringHjerneskadeForente stater
-
Acibadem UniversityThe Scientific and Technological Research Council of TurkeyRekrutteringIdrettsutøvereTyrkia
-
Riphah International UniversityFullført
-
University of MichiganCenters for Disease Control and Prevention; Michigan Army National GuardAktiv, ikke rekrutterende
-
University of MiamiUniversity of Kansas; American Music Therapy AssociationFullført
-
VA Office of Research and DevelopmentFullført
-
Neuro Counsel Hospital, PakistanAl Nafees Medical Hospital, Islamabad; National Institute of Rehabilitation...FullførtSkulderimpingementsyndromPakistan
-
Yeditepe UniversityBahçeşehir UniversityFullført
-
Eastern Mediterranean UniversityFullførtFremover hodestilling | Scapular dyskinesis | Sagittal cervical malalignment | Avrundet skulderKypros
-
Foundation University IslamabadRekrutteringSmerte i korsryggenPakistan